Results 91 to 100 of about 49,826 (161)

Sodium-Glucose Co-Transporter 2 Inhibitors and Heart Failure

The American Journal of Medicine
openaire   +2 more sources

Sodium glucose co transporter 2 inhibitors and Ramadan: Another string to the bow

Indian Journal of Endocrinology and Metabolism, 2014
Jayant Kelwade, Bipin Kumar Sethi, Ayesha Vaseem, V Sri Nagesh   +3 more
doaj   +1 more source

Comparative risk of the neurodegenerative outcomes between sodium-glucose co-transporter 2 (SGLT2) inhibitors and thiazolidinediones in type 2 diabetes: a multicentre cohort study using the Korean healthcare database (2014-2025). [PDF]

BMJ Open
Park SJ, Kim HJ, Seo M, Byun DW, Suh K, Yoo MH, Yang H, Lee I, Kwon SH, Kim M, Mok JO, Kim DY, Sohn SY, Park RW, Seo WW, Kwon SY, Rhee SY, Kwon JM, Cha JM, Park HK.   +19 more
europepmc   +1 more source

Glucosuria as a Biomarker of Adherence to Sodium-Glucose Co-Transporter Protein Type 2 Inhibitors. [PDF]

Patient Prefer Adherence
Escribano-Serrano J, Jiménez-Varo E, Escribano-Cobalea M, Casto-Jarillo C, López-Ceres A, Campos-Dávila E, Hormigo-Pozo A, Franch-Nadal J, Michán-Doña A.   +8 more
europepmc   +1 more source

Myeloproliferative Neoplasms and Sodium-Glucose Co-Transporter-2 Inhibitors: A Case Series

Turkish Journal of Hematology
Pusem Patır, Kübra Çerçi, Erdal Kurtoğlu   +2 more
doaj   +1 more source

Mechanism of Sodium-Glucose Cotransporter-2 Inhibitors for Uricosuria. [PDF]

Electrolyte Blood Press
Bae E.
europepmc   +1 more source

Quantifying the Age of Evidence: Lessons From Cardiovascular Drugs. [PDF]

J Eval Clin Pract
Ferreira MBC, Prasad V.
europepmc   +1 more source

Efficacy of SGLT2 Inhibitors on Clinical Outcomes After Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-Analysis. [PDF]

Endocrinol Diabetes Metab
Daniyal SM, Khatoon NM, Rasool A, Gul I, Tabish S, Asifa S, Khalid A, Aftab Z, Burhan M, Fahim SL, Gondal HT, Nadir MA, Ahmed SZ, Ashraf DA, Ahmed S.   +14 more
europepmc   +1 more source

Effect of the sodium glucose transporter-2 inhibitor dapagliflozin on urine and blood biomarkers in dogs with heart disease. [PDF]

J Vet Intern Med
Massey LK, Ward JL, Crooks AV, Guillot E, Ceron J, Rubio C, Convey V, Tropf M, Ciou MJ, Mochel JP, Oyama MA.   +10 more
europepmc   +1 more source

The SGLT2 inhibitor checklist: a comprehensive review of perioperative and acute phase safety management. [PDF]

Front Endocrinol (Lausanne)
Deng B, Liu W, Chu Q.
europepmc   +1 more source